Clinical Trials in Denver

Showing 1781-1800 of 15,604 trials

Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis

NCT03375047

This Phase 1/2, first-in-human study evaluated the safety and tolerability of single and multiple escalating doses of MRT5005 administered by nebulization to the respiratory tract of adult subjects with cystic fibrosis (CF).

Cystic Fibrosis

Sanofi42 participantsStarted May 2018

Birmingham, Alabama, United States • Denver, Colorado, United States • Gainesville, Florida, United States +13 more locations

COMPLETEDPhase 1/2< 1 mile

An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer

NCT02917993

The purpose of this study is to evaluate the safety and tolerability of itacitinib in combination with osimertinib in subjects with locally advanced or metastatic non-small cell lung cancer (NSCLC).

Lung Cancer

Incyte Corporation59 participantsStarted Dec 2016

La Jolla, California, United States • San Francisco, California, United States • Whittier, California, United States +28 more locations

Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis

An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer

Find Trials by Condition in Denver

Care Planning Framework in Advanced Cancer (ABC123)

LINX Reflux Management System or Fundoplication Clinical Study in Patients With Hiatal Hernia >3 cm

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease

A Prospective Sub-Study of the Global Hypophosphatasia Registry

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

FX Shoulder Prospective Clinical Study

Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

His-Bundle Corrective Pacing in Heart Failure

A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism

LURN: Urinary Urgency Phenotyping Protocol

Homeless Veterans and Peer Whole Health Coaching

Intermuscular Coherence as a Biomarker for ALS

SPEARHEAD-3 Pediatric Study

Early Feasibility Study of the Supira System in Patients Undergoing HRPCI

Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors